AATMAJ2023-01-012023-03-31in-bse-fin:OneOperatingExpenses01Member AATMAJ2023-01-012023-03-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AATMAJ 2022-04-01 2023-03-31 INR Yearly true Cash Flow Indirect Audited Standalone 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0.00 0.00 0.00 0.00 0.00 Notes attached to Audited Standalone Financial Results for the year ended March 31, 2023 1.The above standalone financial results of the company (“the statement”) have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at its Meeting held on August 29, 2023 and have been subjected to audit by the statutory auditors of the company on which the auditors have been expressed an unmodified Opinion. 2. The Standalone Financial results has been prepared in accordance with recognition and measurement principles laid down in the AS as prescribed under section 133 of the companies act, 2013 (“the Act”) read with the companies (accounting standards) Rules, 2021, as amended from time to time and the provisions of the Companies Act, 2013, as applicable and guidelines issued by the securities and exchange board of india (‘SEBI”) and other recognized accounting principles and policies generally accepted in india to the extent possible. 3. These financial results are presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with other relevant rules and circulars issued thereunder. 4.The company is engaged primarily in the business of Operating Multi Specialties Hospitals and all its operations are in India only. Accordingly, there is no separate reportable segment as per AS 17 on ‘Segment Reporting’ in respect of Company. 5. The Company was converted into a public limited Company pursuant to a special resolution passed by the shareholders at the Extra Ordinary General Meeting held on November 16, 2022 and consequently the name of the Company was changed to Aatmaj Healthcare Limited and a fresh certificate of incorporation was issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli, dated December 06, 2022 bearing Corporate Identification Number U85100GJ2014PLC079062. 6. During the year, the Company vide its special resolution passed in the extra ordinary general meeting held at registered office dated 31st July, 2022 has allotted 40,50,000/- Equity Shares as fully paid up Bonus Shares in the ratio of 3:1 (i.e. Three Bonus Shares for every one Equity share held ) by capitalisation of Free reserves of Rs. 4,05,00,000/- and on 7th November, 2022 has allotted 27,00,000/- Equity Shares as fully paid Bonus Shares in the ration of 1:2 (i.e. One Bonus Equity Shares of Rs. 10 each fully paid for every Two Equity shares of Rs. 10 each fully paid held by the shares of the company, by capitalisation of Free reserves of Rs. 2,70,00,000/-. 7. The nominal value of the equity shares of the company was sub divided from Rs. 10 each fully paid to Rs. 5 each fully paid thereby increased the fully paid no of equity shares from 81,00,000 to 1,62,00,000 equity shares of Rs. 5 each fully paid by way of passing of special resolution at the extra ordinary general meeting of the shareholders of the company held on 16th November, 2022. 8. Pursuant to the Initial Public Offer of Equity Shares as approved by the Members of the Company via resolution dated January 23, 2023, the Board of Directors, in their meeting held on June 26, 2023, has allotted total 64,00,000 Equity Shares Rs. 10/- each at price of Rs. 60/- per Equity Share to the successful allottees, whose list have been finalized by the Company, the Registrar to the issue and merchant banker in consultation with National Stock Exchange of India Limited. 9. The trading of equity shares of the Company commenced w.e.f. June 30, 2023 at Emerge Platform of National Stock Exchange of India Ltd. (NSE) DEBT EQUITY RATIO : 0.13 / DEBT SERVICE COVERAGE RATIO : 0.58 AND INTEREST SERVICE COVERAGE RATIO : 0.00 Audited Standalone 271626000.00 264000.00 271890000.00 17416000.00 0.00 0.00 46572000.00 8952000.00 6877000.00 109337000.00 189154000.00 82736000.00 0.00 82736000.00 0.00 82736000.00 21921000.00 1750000.00 23671000.00 59065000.00 0.00 0.00 0.00 590.65 59065000.00 81000000.00 5 0.00 3.64 3.64 0.00 0.00 0.00 Other Expenses 0.00 Other Expenses 109337000.00 8952000.00 6877000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15829000.00 45000.00 -127300000.00 -3788000.00 4818000.00 54406000.00 4620000.00 -67199000.00 -51370000.00 31366000.00 0.00 0.00 0.00 -21921000.00 0.00 53287000.00 0.00 0.00 53287000.00 -30000.00 0.00 0.00 0.00 0.00 4300000.00 0.00 0.00 0.00 0.00 0.00 9840000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -14170000.00 0.00 0.00 -14170000.00 0.00 0.00 0.00 -3259000.00 34496000.00 0.00 0.00 0.00 0.00 -37755000.00 0.00 0.00 -37755000.00 1362000.00 0.00 1362000.00 1807000.00 3169000.00